Authors: VERMORKEN JB CLAESSEN A GALL H VANHOLTEN A VANTINTEREN H MEIJER S STEFFELAAR H BRAKENHOFF J VANBOCHOVE A SCHEPER R MEIJER C HANNA M PINEDO H

Citation: Jb. Vermorken et al., RANDOMIZED PHASE-III TRIAL OF ACTIVE SPECIFIC IMMUNOTHERAPY (ASI) VERSUS CONTROL IN PATIENTS WITH DUKES B2, B3 OR C COLON-CANCER, European journal of cancer, 33, 1997, pp. 722-722